Rchr
J-GLOBAL ID：201801011786005400   Update date: Apr. 27, 2024

Ogawa Kumiko

Ogawa Kumiko
Affiliation and department：
National Institute of Health Sciences

About National Institute of Health Sciences


Homepage URL  (1)： http://www.nihs.go.jp/index-j.html
Research field  (1)： Experimental pathology
Research keywords  (4)： pathology ,  risk analysis ,  carcinogenesis ,  toxicologic pathology
Papers (253)：
  • Hirotoshi Akane, Takeshi Toyoda, Kohei Matsushita, Tomomi Morikawa, Tadashi Kosaka, Hitoshi Tajima, Hiroaki Aoyama, Kumiko Ogawa. Comparison of the sensitivity of histopathological and immunohistochemical analyses and blood hormone levels for early detection of antithyroid effects in rats treated with thyroid peroxidase inhibitors. Journal of applied toxicology : JAT. 2024
  • Kohei Matsushita, Takeshi Toyoda, Hirotoshi Akane, Tomomi Morikawa, Kumiko Ogawa. CD44 expression in renal tubular epithelial cells in the kidneys of rats with cyclosporine-induced chronic kidney disease. Journal of toxicologic pathology. 2024. 37. 2. 55-67
  • Norifumi Takimoto, Yuji Ishii, Tatsuya Mitsumoto, Shinji Takasu, Moeka Namiki, Makoto Shibutani, Kumiko Ogawa. Formation of hepatocyte cytoplasmic inclusions and their contribution to methylcarbamate-induced hepatocarcinogenesis in F344 rats. Toxicological sciences : an official journal of the Society of Toxicology. 2024. 198. 1. 40-49
  • Yuchen Sun, Kosuke Saito, Atsuhito Ushiki, Mitsuhiro Abe, Yoshinobu Saito, Takeru Kashiwada, Yasushi Horimasu, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, et al. Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases. Respiratory research. 2024. 25. 1. 31-31
  • Akiyoshi Nishikawa, Kasuke Nagano, Hajime Kojima, Shoji Fukushima, Kumiko Ogawa. Pathogenesis of chemically induced nasal cavity tumors in rodents: contribution to adverse outcome pathway. Journal of toxicologic pathology. 2024. 37. 1. 11-27
ｍore...
MISC (241)：
  • 松下幸平, 豊田武士, 赤根弘敏, 森川朋美, 小川久美子. AKIからCKDへの移行におけるCD44の役割とバイオマーカーとしての応用. 日本腎臓学会誌(Web). 2022. 64. 3
  • 森川朋美, 豊田武士, 赤根弘敏, 松下幸平, 小川久美子. ラットを用いたオリゴガラクチュロン酸の90日間亜慢性反復経口投与毒性試験. 日本食品化学学会総会・学術大会講演要旨集. 2022. 28th
  • 赤根弘敏, 豊田武士, 松下幸平, 森川朋美, 小坂忠司, 田島均, 青山博昭, 小川久美子. Comparison of histopathological and immunohistochemical methods with blood hormone levels in detection of chemical-induced antithyroid effect in rats. 日本毒性病理学会講演要旨集. 2022. 38th
  • 松下幸平, 豊田武士, 赤根弘敏, 森川朋美, 小川久美子. Potential of CD44 as a biomarker capable of predicting chronicity of drug-induced kidney injury. 日本毒性病理学会講演要旨集. 2022. 38th
  • 豊田武士, 小林琢磨, 三好規之, 松下幸平, 赤根弘敏, 森川朋美, 小川久美子. Effects of repeated oral administration of o-toluidine and o-anisidine metabolites on the rat urinary bladder. 日本毒性病理学会講演要旨集. 2022. 38th
ｍore...
Lectures and oral presentations  (16)：
  • 食薬成分の毒性学的検討課題等について
    (日本食品化学学会第39回食品化学シンポジウム 2023)
  • ICH S1B(R1)のアウトライン
    (第50回日本毒性学会学術年会 2023)
  • 二酸化チタンの安全性評価の現状について
    (第24回医薬品品質フォーラムシンポジウム(web) 2023)
  • 鼻腔発がんの機序についてーAOP的考え方
    (第5回医薬品毒性機序研究会 2022)
  • Further facts from orally exposed nanomaterials.
    (Global Summit on Regulatory Science 2022 2022)
ｍore...
Education (2)：
  • 1989 - 1993 Nagoya City University, Graduate School of Medical Sciences Pathology
  • 1982 - 1988 Nagoya City University Medical School
Work history (9)：
  • 2024/04 - 現在 National Institute of Health Sciences Division of Pathology Senior Researcher
  • 2010/12 - 2024/03 国立医薬品食品衛生研究所 病理部 部長
  • 2009/08 - 2010/11 国立医薬品食品衛生研究所 病理部 室長
  • 2001/06 - 2009/07 名古屋市立東部医療センター 病理部 部長
  • 1997/04 - 2009/07 Nagoya City University Graduate School of Medical Sciences
Show all
Association Membership(s) (10)：
American Association for Cancer Research ,  Society of Toxicology ,  日本免疫毒性学会 ,  日本がん予防学会 ,  Japanese Society of Food Chemistry ,  THE JAPANESE SOCIETY OF PATHOLOGY ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE SOCIETY OF TOXICOLOGY ,  Japanese Society of Toxicologic Pathology ,  International Academy of Toxicologic Pathology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM